{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:52:35Z","timestamp":1771026755812,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.revmed.2009.04.014","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T04:39:09Z","timestamp":1271911149000},"page":"545-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Manifestations oculaires de la maladie de Beh\u00e7et"],"prefix":"10.1016","volume":"31","author":[{"given":"D.","family":"Saadoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cassoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Terrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lehoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bodaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2009.04.014_bib1","first-page":"2093","article-title":"Behcet's syndrome\u00a0\u2013\u00a0lists of clinical and epidemical statistics","volume":"32","author":"Shimizu","year":"1974","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.revmed.2009.04.014_bib2","first-page":"66","article-title":"Revised diagnostic criteria for Behcet's disease in 1987","volume":"28","author":"Mizushima","year":"1988","journal-title":"Ryumachi"},{"key":"10.1016\/j.revmed.2009.04.014_bib3","doi-asserted-by":"crossref","unstructured":"International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078\u201380.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"10.1016\/j.revmed.2009.04.014_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Behcet's disease in Istanbul, Turkey","volume":"42","author":"Azizlerli","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.revmed.2009.04.014_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/ard.36.6.491","article-title":"Behcet's syndrome in 32\u00a0patients in Yorkshire","volume":"36","author":"Chamberlain","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.014_bib6","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1002\/art.24149","article-title":"Population-based prevalence study of Behcet's disease: differences by ethnic origin and low variation by age at immigration","volume":"58","author":"Mahr","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.014_bib7","first-page":"926","article-title":"Manifestations neurologiques de la maladie de Beh\u00e7et","volume":"158","author":"Wechsler","year":"2002","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2009.04.014_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/ard.61.4.365","article-title":"Prevalence of Behcet's disease in an Arab community in Israel","volume":"61","author":"Jaber","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.014_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bjo.2007.137141","article-title":"Clinical and demographic evaluation of Behcet disease among different paediatric age groups","volume":"93","author":"Sungur","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Behcet disease: an analysis of 880\u00a0patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3129\/i08-080","article-title":"Behcet's disease: comparing 3\u00a0decades of treatment response at the National Eye Institute","volume":"43","author":"Kump","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","article-title":"Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet's disease","volume":"8","author":"Wechsler","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2009.04.014_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0161-6420(95)30976-1","article-title":"Sensitivity of laser flare photometry to monitor inflammation in uveitis of the posterior segment","volume":"102","author":"Guex-Crosier","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2009.04.014_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.2006.101550","article-title":"Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45\u00a0patients","volume":"91","author":"Bodaghi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1600-0420.1996.tb00718.x","article-title":"A descriptive study on Behcet's disease","volume":"74","author":"Atmaca","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.revmed.2009.04.014_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of Behcet disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ncprheum0436","article-title":"Behcet's syndrome: disease manifestations, management, and advances in treatment","volume":"3","author":"Yazici","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.revmed.2009.04.014_bib19","first-page":"3343","article-title":"A multicenter clinical open trial of FK\u00a0506\u00a0in refractory uveitis, including Behcet's disease","volume":"23","author":"Mochizuki","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2009.04.014_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1726-4901(08)70159-X","article-title":"Behcet's disease with uveitis in Taiwan","volume":"71","author":"Chung","year":"2008","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.revmed.2009.04.014_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.014_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000060760","article-title":"Clinical aspects and diagnostic guidelines of ocular Behcet's disease","volume":"31","author":"Benezra","year":"1999","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387\u00a0patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2009.04.014_bib24","first-page":"343","article-title":"Pronostic oculaire de la maladie de Behcet","volume":"15","author":"Cochereau-Massin","year":"1992","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.revmed.2009.04.014_bib26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0003-9969(95)00042-N","article-title":"Streptococcus oralis previously identified as uncommon \u2018Streptococcus sanguis\u2019 in Behcet's disease","volume":"40","author":"Narikawa","year":"1995","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.revmed.2009.04.014_bib27","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.4049\/jimmunol.175.9.6133","article-title":"CD8brightCD56+ T\u00a0cells are cytotoxic effectors in patients with active Behcet's uveitis","volume":"175","author":"Ahn","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2009.04.014_bib28","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Behcet disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.014_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08830189709116844","article-title":"Immunotherapy for Behcet's disease","volume":"14","author":"Mochizuki","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.revmed.2009.04.014_bib30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","article-title":"Treatment and visual prognosis in Behcet's disease","volume":"70","author":"Benezra","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Behcet's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2009.04.014_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin\u00a0A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial","volume":"76","author":"Ozyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib33","first-page":"928","article-title":"Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study","volume":"4","author":"Hamuryudan","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.revmed.2009.04.014_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Behcet's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.014_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/0-306-48382-3_118","article-title":"High dose methotrexate for ocular lesions of Behcet's disease. Preliminary short-term results","volume":"528","author":"Davatchi","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.revmed.2009.04.014_bib36","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/ard.2004.025882","article-title":"Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors","volume":"64","author":"Bodaghi","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2009.04.014_bib37","article-title":"Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil","author":"Neri","year":"2008","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib38","first-page":"1355","article-title":"Int\u00e9r\u00eat des bolus de cyclophosphamide dans la maladie de Beh\u00e7et, exp\u00e9rience de 17\u00a0cas","volume":"19","author":"Du","year":"1990","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2009.04.014_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9394(14)72840-5","article-title":"Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease","volume":"118","author":"Whitcup","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib40","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine\u00a0A in Behcet's syndrome","volume":"20","author":"Benezra","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2009.04.014_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780280611","article-title":"Effectiveness of cyclosporin therapy for Behcet's disease","volume":"28","author":"Nussenblatt","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.014_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2008.09.010","article-title":"Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behcet disease","volume":"146","author":"Tabbara","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1021227019915","article-title":"Long-term therapy with low dose cyclosporin\u00a0A in ocular Behcet's disease","volume":"105","author":"Ozdal","year":"2002","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib44","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2009.04.014_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0420.1998.760118.x","article-title":"Cyclosporin-A therapy in severe uveitis of Behcet's disease","volume":"76","author":"Sullu","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.revmed.2009.04.014_bib46","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","article-title":"Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy","volume":"106","author":"Kotake","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2009.04.014_bib47","first-page":"802","article-title":"A phase\u00a0II study of FK506 (tacrolimus) on refractory uveitis associated with Behcet's disease and allied conditions","volume":"35","author":"Sakane","year":"1995","journal-title":"Ryumachi"},{"key":"10.1016\/j.revmed.2009.04.014_bib48","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archopht.123.5.634","article-title":"Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis","volume":"123","author":"Murphy","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 4","key":"10.1016\/j.revmed.2009.04.014_bib49","doi-asserted-by":"crossref","first-page":"495s","DOI":"10.1016\/S0248-8663(02)00665-3","article-title":"Interf\u00e9rons et maladie de Beh\u00e7et","volume":"23","author":"Wechsler","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2009.04.014_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2009.04.014_bib51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ajo.2008.08.038","article-title":"Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behcet disease","volume":"146","author":"Gueudry","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib52","first-page":"1633","article-title":"Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behcet's disease: focusing more on IFN","volume":"32","author":"Kotter","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2009.04.014_bib53","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00417-006-0346-y","article-title":"Results of interferon-alfa therapy in patients with Behcet uveitis","volume":"244","author":"Tugal-Tutkun","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib54","first-page":"S14","article-title":"Infliximab in refractory uveitis due to Behcet's disease","volume":"22","author":"Wechsler","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2009.04.014_bib55","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/kem101","article-title":"Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study","volume":"46","author":"Niccoli","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2009.04.014_bib56","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease: an open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2009.04.014_bib57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1196\/annals.1423.050","article-title":"Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects","volume":"1110","author":"Tognon","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2009.04.014_bib58","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/41.10.1213-c","article-title":"Behcet's syndrome: response to infliximab after failure of etanercept","volume":"41","author":"Estrach","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2009.04.014_bib59","first-page":"264","article-title":"Effect of cataract surgery with intraocular lens implantation on inflammation in chronic uveitis: a longitudinal laser flare photometry study","volume":"33","author":"Tran","year":"1998","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.revmed.2009.04.014_bib60","first-page":"272","article-title":"Intraocular lens implantation following extracapsular cataract extraction in uveitis","volume":"21","author":"Chung","year":"1990","journal-title":"Ophthalmic Surg"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:26:33Z","timestamp":1759335993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866310001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0248866310001153"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2009.04.014","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestations oculaires de la maladie de Beh\u00e7et","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2009.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}